U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.4001G>A (p.Gly1334Asp) AND Marfan syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Dec 18, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001839446.11

Allele description [Variation Report for NM_000138.5(FBN1):c.4001G>A (p.Gly1334Asp)]

NM_000138.5(FBN1):c.4001G>A (p.Gly1334Asp)

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.4001G>A (p.Gly1334Asp)
HGVS:
  • NC_000015.10:g.48474614C>T
  • NG_008805.2:g.176175G>A
  • NM_000138.5:c.4001G>AMANE SELECT
  • NP_000129.3:p.Gly1334Asp
  • NP_000129.3:p.Gly1334Asp
  • LRG_778t1:c.4001G>A
  • LRG_778:g.176175G>A
  • LRG_778p1:p.Gly1334Asp
  • NC_000015.9:g.48766811C>T
  • NM_000138.4:c.4001G>A
  • c.4001G>A
Protein change:
G1334D
Links:
dbSNP: rs191989961
NCBI 1000 Genomes Browser:
rs191989961
Molecular consequence:
  • NM_000138.5:c.4001G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
12

Condition(s)

Name:
Marfan syndrome (MFS)
Synonyms:
MARFAN SYNDROME, TYPE I; Marfan syndrome type 1; Marfan's syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007947; MedGen: C0024796; Orphanet: 284963; Orphanet: 558; OMIM: 154700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001622851New York Genome Center - CSER-NYCKidSeq
criteria provided, single submitter

(NYGC Assertion Criteria 2020)
Uncertain significance
(Jan 29, 2021)
inheritedclinical testing

Citation Link,

SCV004814767All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Dec 18, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown10not providednot provided108544not providedclinical testing
not providedinheritedunknown2not providednot provided2not providedclinical testing

Citations

PubMed

The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD).

Lerner-Ellis JP, Aldubayan SH, Hernandez AL, Kelly MA, Stuenkel AJ, Walsh J, Joshi VA.

Mol Genet Metab. 2014 Jun;112(2):171-6. doi: 10.1016/j.ymgme.2014.03.011. Epub 2014 Apr 2.

PubMed [citation]
PMID:
24793577

Development of a Targeted Multi-Disorder High-Throughput Sequencing Assay for the Effective Identification of Disease-Causing Variants.

Delio M, Patel K, Maslov A, Marion RW, McDonald TV, Cadoff EM, Golden A, Greally JM, Vijg J, Morrow B, Montagna C.

PLoS One. 2015;10(7):e0133742. doi: 10.1371/journal.pone.0133742.

PubMed [citation]
PMID:
26214305
PMCID:
PMC4516357
See all PubMed Citations (3)

Details of each submission

From New York Genome Center - CSER-NYCKidSeq, SCV001622851.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
2not provided1not providednot providedclinical testingnot provided

Description

The inherited c.4001G>A (p.Gly1334Asp) variant identified in the FBN1 gene substitutes a moderately conserved Glycine for Aspartic Acid at amino acid 1334/2872 (coding exon 33/66). This variant is found in 20 heterozygotes and 0 homozygotes in gnomAD(v3.1) with an allele frequency of 1.32e-4. In silico algorithms predict this variant to be Neutral (Provean; score: 3.75) and Tolerated (SIFT; score: 1.00) to the function of the canonical transcript. This variant is reported as a Variant of Uncertain Significance in ClinVar (VarID:42345), including a submission by one clinical lab in which this variant was identified in a family with features of Marfan syndrome. The p.Gly1334Asp variant identified here has also been reported in the literature in a family with Marfan syndrome like features, ticks, possible Tourette Syndrome, speech delay and fine motor delay [PMID:26214305]. The p.Gly1334 residue is within one of the EGF-like calcium binding domains of FBN1 (UniProtKB:P35555). While it has been observed in affected individuals in the literature, the presence of 20 heterozygotes in gnomAD(v3.1) is higher than expected for autosomal dominant Marfan Syndrome. Given this, the inherited c.4001G>A (p.Gly1334Asp) variant identified in the FBN1 gene is reported as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedunknown1not providednot provided1not providednot providednot provided
2inheritedunknown1not providednot provided1not providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004814767.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided10not providednot providedclinical testing PubMed (3)

Description

This missense variant replaces glycine with aspartic acid at codon 1334 of the FBN1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in four individuals with Marfan syndrome-like features (PMID: 24793577, 26214305). Two of these individuals were twin siblings who were also affected with multiple other congenital abnormalities (PMID: 26214305). This variant has been observed to co-occur with another FBN1 variant (c.1006T>C, p.Cys336Arg) in an adolescent individual affected with Marfan syndrome ( doi:10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A2052). This variant has been identified in 2/251238 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided10not providednot providednot provided

Last Updated: Aug 25, 2024